Drug Trial Radar · NCT02374931
18F-FES PET/CT in Imaging Patients With Desmoid Tumors
Last checked: Nov 20, 2026Latest source record: Oct 3, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
3
Actual
Start
Apr 2015
Primary completion
Jul 2017
Study completion Dec 2017
Sponsor
- Lead sponsor
- Vanderbilt-Ingram Cancer CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Mar 2, 2015
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This pilot clinical trial studies fluorine (F)-18 16 alpha-fluoroestradiol (18F-FES) positron emission tomography (PET)/computed tomography (CT) in imaging patients with desmoid tumors. 18F-FES binds to estrogen receptors, which are present on desmoid tumors, and gives off radiation that may be detected by PET and CT scans. The PET/CT scan forms an image that may show where tumor cells with estrogen receptors can be found in the body.
Conditions
- Deep Fibromatosis/Desmoid Tumor
- Familial Adenomatous Polyposis
Interventions
F-18 16 Alpha-FluoroestradiolDrug
Undergo 18F-FES PET/CT
Positron Emission TomographyProcedure
Undergo 18F-FES PET/CT
Computed TomographyProcedure
Undergo 18F-FES PET/CT
Laboratory Biomarker AnalysisOther
Correlative studies
Primary outcomes
What the sponsor says the trial is designed to measure.
- Standard uptake value (SUV) measured as percent injected dose per ccTime frame: Initial visit, average within 24 hours of imaging
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.